Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:DRAD

Digirad (DRAD) Stock Price, News & Analysis

Digirad logo

About Digirad Stock (NASDAQ:DRAD)

Advanced Chart

Key Stats

Today's Range
$1.93
$2.00
50-Day Range
$2.79
$4.65
52-Week Range
$1.99
$8.84
Volume
2,251 shs
Average Volume
485,592 shs
Market Capitalization
$9.33 million
P/E Ratio
N/A
Dividend Yield
112.24%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DRAD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Digirad and its competitors with MarketBeat's FREE daily newsletter.

DRAD Stock News Headlines

Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
Rock icon Jeff Beck dead at 78
See More Headlines

DRAD Stock Analysis - Frequently Asked Questions

Digirad Co. (NASDAQ:DRAD) released its quarterly earnings results on Wednesday, November, 18th. The medical equipment provider reported ($0.19) earnings per share for the quarter, missing the consensus estimate of $0.15 by $0.34. The medical equipment provider earned $30.35 million during the quarter. Digirad had a negative net margin of 5.32% and a negative trailing twelve-month return on equity of 3.75%.

Digirad shares reverse split before market open on Wednesday, June 5th 2019.The 1-10 reverse split was announced on Friday, May 31st 2019. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, June 4th 2019. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Digirad investors own include AT&T (T), GE Aerospace (GE), Gilead Sciences (GILD), Biocept (BIOC), Exelixis (EXEL), Pfizer (PFE) and Rigel Pharmaceuticals (RIGL).

Company Calendar

Last Earnings
11/18/2020
Today
7/06/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Electromedical Equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:DRAD
Fax
N/A
Employees
618
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$4.63 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$114.18 million
Cash Flow
$2.84 per share
Price / Cash Flow
0.69
Book Value
$10.30 per share
Price / Book
0.19

Miscellaneous

Free Float
N/A
Market Cap
$9.33 million
Optionable
Not Optionable
Beta
0.18
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NASDAQ:DRAD) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners